Characterization and Support of Neurodevelopmental Disorders Associated With Congenital Cardiac malfoRmations - Neonatal
A legfontosabb adatok
- Ki végzi
- Nantes University Hospital
- Hol
- Franciaország8 helyszín, 1 országbanVálassz országot a helyszínekhez
- Azonosító
- Állapot
- Toboroz
- Résztvevők
- 450 fő, tervezett
- Kezdés
- 2025. febr. 28.
- Várható befejezés
- 2028. aug. 28.
- A vizsgálat típusa
- Megfigyeléses
- A vizsgált kezelések
- Neurodevelopmental assessment (Bayley-IV)
- Biological sampling
- ELFE dietary questionnaire
- Post-Traumatic Stress Questionnaire IES-R (Impact of Event Scale - Revised)
- Data collection for the study (Cardiovascular, developemental, fetal, pregnancy, MRI)
- A regiszteradat frissítve
- 2026. július 1.
Ki vehet részt
MI-összefoglaló
A vizsgálat saját részvételi feltételeiből. Gép olvasta ki az oldalon álló regiszterszövegből, ezért tévedhet. Hogy ki vehet részt, azt a lenti regiszterszöveg és a vizsgálat csapata dönti el.
The trial is looking for unborn babies with a serious heart defect found before birth, and their biological parents. The study follows the babies' development after birth.
- Életkor
- Unborn babies (fetuses), followed after birth, and their parents.
- Nem
- All
- A betegség stádiuma
- A heart defect present from birth, found before birth. It must be serious enough to need heart surgery in the first three months of life.
A részvétel fő kizáró okai
- Parents are considering a medical end to the pregnancy
- A genetic condition or a syndrome with other birth defects found before joining
- Parents not covered by social security or a similar system
- Parents who do not understand French well
- No written consent from both parents
A regiszter feltételei, szó szerint
Mind a 9 feltétel megnézéseKevesebb
Ki nem vehet részt
- Genetic anomaly or malformative syndrome identified prior to inclusion
- Medical termination of pregnancy considered
Egyéb feltételek
- The inclusion criteria are as follows:
- Fetus with a congenital heart defect (CHD) detected prenatally (prenatal diagnosis of the heart defect)
- Fetus with a critical CHD defined as requiring cardiac surgery during the first three months of the infant's life
- Parents affiliated with or beneficiaries of a social security or equivalent system
- Parents' good understanding of the French language
- Voluntary, informed, and written consent from both parents for themselves and the unborn child; Criteria for parents*:
- Biological parents *The inclusion of the father in the project does not limit the participation of the child (patient) in the study; *The father will be encouraged to participate in the project by providing a blood sample to create a trio (mother/father/infant) for future genetic analyses; However, if the father is unavailable or does not consent to the collection and storage of samples for analysis (as part of the CATAMARAN study or future research projects related to biobanking), the child can still be included in the study
Ennek a vizsgálatnak nincs helyszíne itt: Egyesült Államok.
Egy országban van helyszíne. Válassz országot, hogy lásd a helyszíneket.
A vizsgálatról
Mit akar kideríteni a vizsgálat
Congenital heart defects (CHD), as the leading cause of birth defects, affect 12 million people globally and approximately 41,000 newborns each year in Europe. CHD presents a significant public health concern due to its association with high morbidity and mortality rates across the lifespan. Over 50% of infants born with critical CHD will develop neurodevelopmental disorders (NDD), requiring specialized care and impacting their quality of life. NDDs, involving early and persistent disruptions in cognitive, emotional, and behavioral development due to abnormal brain development, are highly variable. They may impact language, learning, motor skills, intellectual efficiency, social cognition, attention, memory, and executive functions, often accompanied by psychosocial difficulties. These hidden disabilities constitute the primary long-term sequelae of CHD, surpassing even cardiovascular complications in impact, and affect children who often undergo multiple cardiac surgeries during early childhood. NDDs are associated not only with complex CHDs but also with simpler CHDs that are repaired in early childhood and considered 'cured.'
A teljes eredeti leírásKevesebb
The origin of CHD-associated NDDs remains largely unknown. While few genetic or environmental causes have been identified, recent research suggests a possible common origin linking heart malformations and neurodevelopmental abnormalities. The CATAMARAN neonatal cohort project aims to detect developmental delays associated with CHD as early as six months of age and to identify both individual susceptibility factors and acquired vulnerabilities contributing to the development of NDDs in infants with CHD.
A vizsgálat csoportja
- Study population (Newborns with congenital heart defects and their two parents)
The study population will consist of 150 fetuses with a prenatally diagnosed critical congenital heart defect (CHD), at high risk of developing developmental delays, and their two parents.
Kezelés: Neurodevelopmental assessment (Bayley-IV), Biological sampling, ELFE dietary questionnaire, Post-Traumatic Stress Questionnaire IES-R (Impact of Event Scale - Revised) és Data collection for the study (Cardiovascular, developemental, fetal, pregnancy, MRI)
Kérdések a vizsgálat csapatának
- Milyen gyakran kell bejárnom, és egy-egy alkalom mennyi ideig tart?
- Megtérítik az utazási költséget?
- Megtarthatom a saját orvosomat?
- Mi történik, ha ki akarok lépni?
Contact the study team: see the registry record → Contacts and Locations
Oldal nyomtatása az orvosomnakAdatok és források
- Regiszteradat
- Szerepel a ClinicalTrials.gov-on.
- Hivatalos cím
- CATAMARAN - Neonatal Cohort : Characterization and Support of Neurodevelopmental Disorders Associated With Congenital Cardiac malfoRmations - Neonatal
- MI-összefoglaló
- A vizsgálat saját részvételi feltételeiből. Gépi kiolvasás: 2026. november 14.
- Publikációk
- A regiszteradat frissítve
- 2026. július 1.